Bottom line
What is PADCX's expense ratio?
PADCX's expense ratio is 1.72%, or about $172 a year on every $10,000 invested. That is more expensive than 61% of alternatives funds we track (median 1.54%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Dec 23, 2025
PADCX fee table
| Net expense ratio | 1.72% |
|---|---|
| Gross expense ratio | 1.73% |
| Management fee | 0.58% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.14% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.01% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What PADCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PADCX | $275 | $544 | $938 | $1,836 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.72% expense ratio costs roughly $89,500 in lost growth, versus about $81,400 for the median alternatives fund (1.54%).